Press Releases
Press Releases
Aigenpulse launches data analysis suite to automate flow cytometry
Life science and data technology innovator, Aigenpulse, is launching its CytoML Experiment Suite – an automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes. With it, users will...
Press Releases
Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
The facility is adjacent to the company's biologics manufacturing facility, which recently doubled production capacity with...
Press Releases
GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced a partnership with GC Pharma, a South Korean biopharmaceutical company formerly known as Green Cross Corporation, to discover and develop novel hemophilia therapies. GC Pharma...
Press Releases
Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
Co-Diagnostics Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that it has entered into an agreement with Arches Research, Inc, a CLIA laboratory and subsidiary of Polarity TE, Inc, to...
Press Releases
INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that Thermo Fisher Scientific, the world leader in serving science, has signed a letter of...
Drug Research
PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line
PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced on August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Development and Manufacturing Organization) company in Korea.
With the new...
Drug Research
Catalent and Exelixis Enter into Collaboration, License, and Exclusive Option Agreement to Develop ADC Leveraging SMARTag Bioconjugation Technology
Exelixis, Inc. and Catalent announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates (ADCs) for Exelixis using Catalent’s proprietary SMARTag® site-specific bioconjugation technology.
Under the terms of the agreement, Catalent will use its SMARTag® bioconjugation...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.